State Street’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-583,000
Closed -$56.9M 3831
2015
Q1
$56.9M Buy
583,000
+52,350
+10% +$5.11M 0.01% 1160
2014
Q4
$49.2M Sell
530,650
-39,392
-7% -$3.65M ﹤0.01% 1239
2014
Q3
$39.2M Buy
570,042
+58,316
+11% +$4.01M ﹤0.01% 1302
2014
Q2
$53.6M Sell
511,726
-10,041
-2% -$1.05M 0.01% 1201
2014
Q1
$43.3M Sell
521,767
-14,275
-3% -$1.18M ﹤0.01% 1285
2013
Q4
$34.7M Buy
536,042
+59,679
+13% +$3.86M ﹤0.01% 1402
2013
Q3
$30.2M Buy
476,363
+32,768
+7% +$2.07M ﹤0.01% 1447
2013
Q2
$18.6M Buy
+443,595
New +$18.6M ﹤0.01% 1671